A critical discovery in cancer investigation is occurring with the use of VHH fragments to re-engage damaged p53. This essential malignant suppressor protein is frequently disabled in various forms of cancer, resulting https://agency-social.com/story7003111/nanobodies-reactivate-p53-a-promising-pathway-for-cancer-therapy